NASDAQ:MYOS - MYOS Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.55 +0.02 (+1.31 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$1.53
Today's Range$1.51 - $1.59
52-Week Range$1.03 - $2.38
Volume43,000 shs
Average Volume102,005 shs
Market Capitalization$9.99 million
P/E Ratio-2.22
Dividend YieldN/A
Beta1.46

About MYOS (NASDAQ:MYOS)

MYOS RENS Technology Inc., a bionutrition and biotherapeutics company, focuses on the discovery, development, and commercialization of nutritional and therapeutic products for maintaining and enhancing the health and performance of muscle tissue. The company primarily focuses on developing the products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity. Its products include Re Muscle Health products, a direct-to-consumer portfolio of muscle health bars, meal replacement shakes, and daily supplement powders; and Qurr line of products comprising flavored puddings, powders, and shakes. The company sells its Re Muscle Health products through e-commerce Website remusclehealth.com; and Qurr line of products through convenient direct online ordering without a prescription. MYOS RENS Technology Inc. has a research agreement with the University of California to study the effects Of Fortetropin on skeletal muscle protein synthetic rate in older men and women; and Rutgers University for the discovery development and commercialization of products that improve muscle health and performance. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.

Receive MYOS News and Ratings via Email

Sign-up to receive the latest news and ratings for MYOS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MYOS
CUSIPN/A
Phone973-509-0444

Debt

Debt-to-Equity RatioN/A
Current Ratio4.93
Quick Ratio0.89

Price-To-Earnings

Trailing P/E Ratio-2.22
Forward P/E Ratio-4.43
P/E GrowthN/A

Sales & Book Value

Annual Sales$530,000.00
Price / Sales19.48
Cash FlowN/A
Price / CashN/A
Book Value$0.69 per share
Price / Book2.25

Profitability

EPS (Most Recent Fiscal Year)($0.69)
Net Income$-4,050,000.00
Net Margins-959.35%
Return on Equity-95.44%
Return on Assets-87.00%

Miscellaneous

Employees10
Outstanding Shares6,660,000

MYOS (NASDAQ:MYOS) Frequently Asked Questions

What is MYOS's stock symbol?

MYOS trades on the NASDAQ under the ticker symbol "MYOS."

How were MYOS's earnings last quarter?

MYOS Co. (NASDAQ:MYOS) posted its quarterly earnings data on Tuesday, March, 27th. The company reported ($0.17) earnings per share for the quarter. The company earned $0.16 million during the quarter. MYOS had a negative return on equity of 95.44% and a negative net margin of 959.35%. View MYOS's Earnings History.

When is MYOS's next earnings date?

MYOS is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for MYOS.

Who are some of MYOS's key competitors?

Who are MYOS's key executives?

MYOS's management team includes the folowing people:
  • Dr. Robert Joseph Hariri, Exec. Chairman & Chairman of the Scientific Advisory Board (Age 59)
  • Mr. Joseph Mannello, CEO & Director (Age 60)
  • Mr. Ren Ren, Global Chairman (Age 56)
  • Mr. Joseph DiPietro, Controller
  • Mr. Magshoud Dariani, Chief Technology Officer

Has MYOS been receiving favorable news coverage?

Media coverage about MYOS stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. MYOS earned a coverage optimism score of 0.24 on Accern's scale. They also assigned news articles about the company an impact score of 45.85 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of MYOS?

Shares of MYOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MYOS's stock price today?

One share of MYOS stock can currently be purchased for approximately $1.55.

How big of a company is MYOS?

MYOS has a market capitalization of $9.99 million and generates $530,000.00 in revenue each year. The company earns $-4,050,000.00 in net income (profit) each year or ($0.69) on an earnings per share basis. MYOS employs 10 workers across the globe.

How can I contact MYOS?

MYOS's mailing address is 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ, 07927. The company can be reached via phone at 973-509-0444 or via email at [email protected]


MarketBeat Community Rating for MYOS (MYOS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  46 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about MYOS and other stocks. Vote "Outperform" if you believe MYOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYOS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MYOS (NASDAQ:MYOS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/22/2016 forward)

Earnings

MYOS (NASDAQ:MYOS) Earnings History and Estimates Chart

Earnings by Quarter for MYOS (NASDAQ:MYOS)

MYOS (NASDAQ:MYOS) Earnings Estimates

2018 EPS Consensus Estimate: ($0.31)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.08)($0.08)($0.08)
Q2 20181($0.08)($0.08)($0.08)
Q3 20181($0.08)($0.08)($0.08)
Q4 20181($0.07)($0.07)($0.07)

MYOS (NASDAQ MYOS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2018        
5/9/2018Q1($0.08)($0.19)$0.18 million$0.06 millionViewN/AView Earnings Details
3/27/2018Q4 2017($0.17)$0.16 millionViewN/AView Earnings Details
11/14/2017Q3 2017($0.13)$0.16 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.19)$0.06 millionViewN/AView Earnings Details
5/12/2017Q1 2017($0.20)$0.15 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.14)$0.03 millionViewN/AView Earnings Details
11/14/2016Q3 2016($0.17)$0.04 millionViewN/AView Earnings Details
8/12/2016Q2 2016($0.30)$0.07 millionViewN/AView Earnings Details
5/13/2016Q1 2016($0.31)$0.20 millionViewN/AView Earnings Details
5/14/2015Q1 2015($0.50)$0.01 millionViewN/AView Earnings Details
11/14/2014Q3 2014($0.24)($0.73)$1.90 million$0.11 millionViewN/AView Earnings Details
8/14/2014Q214($0.20)($0.32)$1.70 million$1.68 millionViewN/AView Earnings Details
5/16/2014Q1 2014($0.16)$1.55 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

MYOS (NASDAQ:MYOS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

MYOS (NASDAQ MYOS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.70%
Institutional Ownership Percentage: 1.72%
Insider Trading History for MYOS (NASDAQ:MYOS)

MYOS (NASDAQ MYOS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/25/2018Christopher PechockDirectorBuy80,645$1.24$99,999.80View SEC Filing  
4/25/2018Joseph MannelloCEOBuy221,774$1.24$274,999.76View SEC Filing  
12/21/2017Joseph MannelloCEOBuy20,336$1.46$29,690.56274,765View SEC Filing  
12/8/2017Joseph MannelloCEOBuy38,119$1.35$51,460.65233,629View SEC Filing  
12/6/2017Joseph MannelloCEOBuy16,819$1.35$22,705.65233,629View SEC Filing  
11/16/2017Joseph MannelloCEOBuy25,000$1.31$32,750.00203,560View SEC Filing  
11/14/2017Joseph MannelloCEOBuy11,750$1.27$14,922.50203,560View SEC Filing  
9/23/2016Zhengguang LyuDirectorBuy50,000$1.70$85,000.0083,505View SEC Filing  
9/6/2016Zhengguang LyuDirectorBuy23,505$1.60$37,608.0010,600View SEC Filing  
6/17/2016Zhengguang LyuDirectorBuy10,000$1.65$16,500.0010,000View SEC Filing  
4/8/2016Joseph MannelloDirectorBuy4,417$1.96$8,657.32177,879View SEC Filing  
4/5/2016Joseph MannelloDirectorBuy6,128$1.75$10,724.00170,962View SEC Filing  
9/29/2015Robert J. HaririDirectorBuy2,300$2.68$6,164.0092,364View SEC Filing  
9/25/2015Robert J. HaririDirectorBuy12,150$2.44$29,646.0090,064View SEC Filing  
9/11/2015Robert J. HaririDirectorBuy4,000$1.73$6,920.0077,914View SEC Filing  
9/8/2015Robert J. HaririDirectorBuy25,250$1.71$43,177.5073,914View SEC Filing  
9/4/2015Louis J AronneDirectorBuy5,000$1.76$8,800.0022,200View SEC Filing  
8/28/2015Robert J HaririDirectorBuy2,750$1.74$4,785.0048,664View SEC Filing  
12/4/2014Robert J HaririDirectorBuy2,200$8.16$17,952.00View SEC Filing  
8/18/2014Peter DiamandisDirectorBuy3,444$14.51$49,972.44View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

MYOS (NASDAQ MYOS) News Headlines

Source:
DateHeadline
Brokers Offer Predictions for MYOS Co.s Q2 2018 Earnings (MYOS)Brokers Offer Predictions for MYOS Co.'s Q2 2018 Earnings (MYOS)
www.americanbankingnews.com - May 18 at 7:13 AM
MYOS: Several Development-Related Milestones UpcomingMYOS: Several Development-Related Milestones Upcoming
finance.yahoo.com - May 16 at 5:54 PM
MYOS RENS Technologys (MYOS) CEO Joseph Mannello on Q1 2018 Results - Earnings Call TranscriptMYOS RENS Technology's (MYOS) CEO Joseph Mannello on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 13 at 8:11 AM
MYOS (MYOS) Issues  Earnings ResultsMYOS (MYOS) Issues Earnings Results
www.americanbankingnews.com - May 11 at 6:17 PM
MYOS RENS Technology Reports First Quarter Financial ResultsMYOS RENS Technology Reports First Quarter Financial Results
finance.yahoo.com - May 9 at 5:45 PM
MYOS (MYOS) to Release Earnings on ThursdayMYOS (MYOS) to Release Earnings on Thursday
www.americanbankingnews.com - May 4 at 10:12 AM
MYOS RENS Technology Announces the Date for the Release of First Quarter 2018 Results, Conference Call and WebcastMYOS RENS Technology Announces the Date for the Release of First Quarter 2018 Results, Conference Call and Webcast
finance.yahoo.com - May 3 at 5:32 PM
MYOS (MYOS) Upgraded to "Hold" by ValuEngineMYOS (MYOS) Upgraded to "Hold" by ValuEngine
www.americanbankingnews.com - May 2 at 11:37 PM
MYOS Co. (MYOS) Director Buys $99,999.80 in StockMYOS Co. (MYOS) Director Buys $99,999.80 in Stock
www.americanbankingnews.com - April 27 at 7:26 PM
Insider Buying: MYOS Co. (MYOS) CEO Acquires 221,774 Shares of StockInsider Buying: MYOS Co. (MYOS) CEO Acquires 221,774 Shares of Stock
www.americanbankingnews.com - April 27 at 7:10 PM
Free Research Report as Lipocine Announced FY17 Financial ResultsFree Research Report as Lipocine Announced FY17 Financial Results
finance.yahoo.com - April 20 at 8:15 AM
MYOS: A New Product For Sports NutritionMYOS: A New Product For Sports Nutrition
finance.yahoo.com - April 12 at 5:50 PM
Was MYOS RENS Technology Inc’s (NASDAQ:MYOS) Earnings Growth Better Than The Industry’s?Was MYOS RENS Technology Inc’s (NASDAQ:MYOS) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - April 10 at 5:36 PM
MYOS RENS Technology introduces a new sports nutrition product line, YolkedMYOS RENS Technology introduces a new sports nutrition product line, Yolked
seekingalpha.com - April 10 at 8:14 AM
MYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked™, and Earns Prestigious "Certified For Sport®" Certification From NSF InternationalMYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked™, and Earns Prestigious "Certified For Sport®" Certification From NSF International
finance.yahoo.com - April 10 at 8:14 AM
MYOS RENS Technology (MYOS) Upgraded by ValuEngine to SellMYOS RENS Technology (MYOS) Upgraded by ValuEngine to Sell
www.americanbankingnews.com - April 9 at 11:35 AM
Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation BrandsDetailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands
www.nasdaq.com - April 6 at 8:15 AM
Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJs Restaurants — What Drives Growth in Todays Competitive LandscapeDetailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJ's Restaurants — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - April 6 at 8:15 AM
Equities Analysts Offer Predictions for MYOS RENS Technology Incs Q1 2018 Earnings (MYOS)Equities Analysts Offer Predictions for MYOS RENS Technology Inc's Q1 2018 Earnings (MYOS)
www.americanbankingnews.com - April 5 at 7:38 AM
MYOS RENS Technology to Present at the MicroCap Conference April 10 in New York City at the Essex HouseMYOS RENS Technology to Present at the MicroCap Conference April 10 in New York City at the Essex House
finance.yahoo.com - April 3 at 5:42 PM
MYOS: Initiation ReportMYOS: Initiation Report
finance.yahoo.com - April 3 at 5:42 PM
MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017
finance.yahoo.com - March 28 at 5:27 PM
BRIEF-Myos Rens Says Qtrly Net Loss Rose 44 Pct To $1.1 MLNBRIEF-Myos Rens Says Qtrly Net Loss Rose 44 Pct To $1.1 MLN
www.reuters.com - March 28 at 8:17 AM
MYOS RENS Technology Inc. to Host Earnings CallMYOS RENS Technology Inc. to Host Earnings Call
finance.yahoo.com - March 28 at 8:17 AM
MYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial ResultsMYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial Results
www.prnewswire.com - March 27 at 6:19 PM
MYOS RENS Technology (MYOS) Scheduled to Post Earnings on ThursdayMYOS RENS Technology (MYOS) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - March 22 at 1:16 AM
MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Year Ended December 31, 2017 Results, Conference Call and WebcastMYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Year Ended December 31, 2017 Results, Conference Call and Webcast
finance.yahoo.com - March 20 at 5:25 PM
MYOS RENS Technology to Showcase Fortetropin® and the Qurr® Line of Muscle Health Products at the 2018 Arnold Sports Festival in Columbus, OH from March 2-4, 2018MYOS RENS Technology to Showcase Fortetropin® and the Qurr® Line of Muscle Health Products at the 2018 Arnold Sports Festival in Columbus, OH from March 2-4, 2018
finance.yahoo.com - February 15 at 8:56 AM
MYOS RENS Technology (MYOS) Upgraded by ValuEngine to "Sell"MYOS RENS Technology (MYOS) Upgraded by ValuEngine to "Sell"
www.americanbankingnews.com - February 4 at 9:14 PM
MYOS RENS Technology Launches 30-Day Qurr® Fortetropin® ChallengeMYOS RENS Technology Launches 30-Day Qurr® Fortetropin® Challenge
www.prnewswire.com - January 16 at 6:24 AM
MYOS RENS Technology CEO Issues Shareholder LetterMYOS RENS Technology CEO Issues Shareholder Letter
finance.yahoo.com - January 11 at 9:52 AM
Insider Buying: MYOS RENS Technology Inc (MYOS) CEO Purchases 20,336 Shares of StockInsider Buying: MYOS RENS Technology Inc (MYOS) CEO Purchases 20,336 Shares of Stock
www.americanbankingnews.com - December 26 at 6:20 PM
Insider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 16,819 Shares of StockInsider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 16,819 Shares of Stock
www.americanbankingnews.com - December 8 at 11:16 PM
Insider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 38,119 Shares of StockInsider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 38,119 Shares of Stock
www.americanbankingnews.com - December 8 at 8:52 PM
MYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And WomenMYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And Women
finance.yahoo.com - December 6 at 9:42 AM
MYOS RENS Technology Inc. (MYOS) CEO Acquires $14,922.50 in StockMYOS RENS Technology Inc. (MYOS) CEO Acquires $14,922.50 in Stock
www.americanbankingnews.com - November 16 at 9:44 PM
MYOS RENS Technology Inc. (MYOS) CEO Acquires $32,750.00 in StockMYOS RENS Technology Inc. (MYOS) CEO Acquires $32,750.00 in Stock
www.americanbankingnews.com - November 16 at 9:24 PM
MYOS RENS Technology Inc. (MYOS) Releases  Earnings ResultsMYOS RENS Technology Inc. (MYOS) Releases Earnings Results
www.americanbankingnews.com - November 15 at 1:05 PM
MYOS RENS Technology Reports Third Quarter 2017 Financial ResultsMYOS RENS Technology Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 15 at 6:38 AM
MYOS RENS Technology Inc. Launches Collegiate Sports Marketing PlatformMYOS RENS Technology Inc. Launches Collegiate Sports Marketing Platform
finance.yahoo.com - November 9 at 6:46 AM
Who Really Owns MYOS RENS Technology Inc (MYOS)?Who Really Owns MYOS RENS Technology Inc (MYOS)?
finance.yahoo.com - November 4 at 6:53 AM
An Initiative To Promote Muscle Health And Its Importance In Fighting Aging And Speeding Up Post Workout RecoveryAn Initiative To Promote Muscle Health And Its Importance In Fighting Aging And Speeding Up Post Workout Recovery
globenewswire.com - October 27 at 8:16 AM
Pro Football Legends, the Commercial Marketing Arm of the NFL Alumni, Launches Partnership with MYOS RENS Technology Inc. in Optimal Bowl and Wellness ChallengePro Football Legends, the Commercial Marketing Arm of the NFL Alumni, Launches Partnership with MYOS RENS Technology Inc. in Optimal Bowl and Wellness Challenge
finance.yahoo.com - October 27 at 8:16 AM
BRIEF-Myos Rens Technology Inc appoints Joseph Mannello as permanent CEOBRIEF-Myos Rens Technology Inc appoints Joseph Mannello as permanent CEO
www.reuters.com - September 22 at 10:00 AM
MYOS RENS Technology Inc. Appoints Joseph Mannello as Permanent Chief Executive OfficerMYOS RENS Technology Inc. Appoints Joseph Mannello as Permanent Chief Executive Officer
finance.yahoo.com - September 22 at 10:00 AM
MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
finance.yahoo.com - August 25 at 8:58 AM
MYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las VegasMYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las Vegas
finance.yahoo.com - July 13 at 7:06 AM
How These Generic Drugs Stocks are Faring? -- MYOS RENS Technology, Akari Therapeutics, Flexion Therapeutics, and Zynerba PharmaHow These Generic Drugs Stocks are Faring? -- MYOS RENS Technology, Akari Therapeutics, Flexion Therapeutics, and Zynerba Pharma
www.prnewswire.com - May 19 at 7:13 PM
MYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launchMYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launch
us.rd.yahoo.com - March 31 at 9:26 AM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - February 21 at 6:13 PM

SEC Filings

MYOS (NASDAQ:MYOS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

MYOS (NASDAQ:MYOS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

MYOS (NASDAQ MYOS) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.